Bicycle Therapeutics
Focus: Bicycle Therapeutics is a Cambridge-based biotechnology company specializing in bicyclic peptide therapeutics for oncology and other indications. The company operates as a focused mid-stage biotech with a proprietary peptide platform technology.
Profile data last refreshed 1h ago · AI intelligence enriched 2mo ago
Open Jobs
4+1 this month
Stable — net +1 jobs in 30d
3 added, 2 removed. Backfill posture.
Should You Work at Bicycle Therapeutics?
AI assessmentSuited for scientists and technical professionals seeking deep platform expertise and startup-like autonomy; less ideal for those needing near-term regulatory catalysts or broad internal mobility.
Why Work Here
- Proprietary bicyclic peptide platform offers differentiated technology exposure and competitive moat in early-stage oncology
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
BT1718
Advanced Solid TumoursClinical Trials (1)
NCT03486730BT1718 in Patients with Advanced Solid Tumours.
Phase 1/2Help build intelligence for Bicycle Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.